 | • レポートコード：MRC2Q12-07881 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：消費財 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、組換え成長因子の世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に組換え成長因子のグローバル市場のxxx％を占める「組換え人間上皮成長因子」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「科学研究」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 組換え成長因子の中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの組換え成長因子市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 組換え成長因子のグローバル主要プレイヤーには、Thermo Fisher、Irvine Scientific、Biologics International Corp、R&D Systems、BioLegend、Corning、VWR、CellGenix GmbH、Shenandoah Biotechnologyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 組換え成長因子市場は、種類と用途によって区分されます。世界の組換え成長因子市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 組換え人間上皮成長因子、その他 【用途別セグメント】 科学研究、工業生産 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 組換え成長因子製品概要 - 種類別市場（組換え人間上皮成長因子、その他） - 用途別市場（科学研究、工業生産） - 調査の目的 ・エグゼクティブサマリー - 世界の組換え成長因子販売量予測2017-2028 - 世界の組換え成長因子売上予測2017-2028 - 組換え成長因子の地域別販売量 - 組換え成長因子の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別組換え成長因子販売量 - 主要メーカー別組換え成長因子売上 - 主要メーカー別組換え成長因子価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（組換え人間上皮成長因子、その他） - 組換え成長因子の種類別販売量 - 組換え成長因子の種類別売上 - 組換え成長因子の種類別価格 ・用途別市場規模（科学研究、工業生産） - 組換え成長因子の用途別販売量 - 組換え成長因子の用途別売上 - 組換え成長因子の用途別価格 ・北米市場 - 北米の組換え成長因子市場規模（種類別、用途別） - 主要国別の組換え成長因子市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの組換え成長因子市場規模（種類別、用途別） - 主要国別の組換え成長因子市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の組換え成長因子市場規模（種類別、用途別） - 主要国別の組換え成長因子市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の組換え成長因子市場規模（種類別、用途別） - 主要国別の組換え成長因子市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの組換え成長因子市場規模（種類別、用途別） - 主要国別の組換え成長因子市場規模（トルコ、サウジアラビア） ・企業情報 Thermo Fisher、Irvine Scientific、Biologics International Corp、R&D Systems、BioLegend、Corning、VWR、CellGenix GmbH、Shenandoah Biotechnology ・産業チェーン及び販売チャネル分析 - 組換え成長因子の産業チェーン分析 - 組換え成長因子の原材料 - 組換え成長因子の生産プロセス - 組換え成長因子の販売及びマーケティング - 組換え成長因子の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 組換え成長因子の産業動向 - 組換え成長因子のマーケットドライバー - 組換え成長因子の課題 - 組換え成長因子の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Recombinant Growth Factors is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Recombinant Growth Factors is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Recombinant Growth Factors is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Recombinant Growth Factors include Thermo Fisher, Irvine Scientific, Biologics International Corp, R&D Systems, BioLegend, Corning, VWR, CellGenix GmbH and Shenandoah Biotechnology, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Recombinant Growth Factors manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Recombinant Growth Factors market. Further, it explains the major drivers and regional dynamics of the global Recombinant Growth Factors market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Thermo Fisher
Irvine Scientific
Biologics International Corp
R&D Systems
BioLegend
Corning
VWR
CellGenix GmbH
Shenandoah Biotechnology
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Recombinant Growth Factors Segment by Type
Recombinant Human Epidermal Growth Factor
Other
Recombinant Growth Factors Segment by Application
Scientific Research
Industrial Production
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Recombinant Growth Factors market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Recombinant Growth Factors, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Recombinant Growth Factors, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Recombinant Growth Factors, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Recombinant Growth Factors sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Recombinant Growth Factors market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Recombinant Growth Factors sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Thermo Fisher, Irvine Scientific, Biologics International Corp, R&D Systems, BioLegend, Corning, VWR, CellGenix GmbH and Shenandoah Biotechnology, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Recombinant Growth Factors in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Recombinant Growth Factors manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Growth Factors sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Recombinant Growth Factors Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Growth Factors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Recombinant Human Epidermal Growth Factor
1.2.3 Other
1.3 Market by Application
1.3.1 Global Recombinant Growth Factors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Scientific Research
1.3.3 Industrial Production
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Recombinant Growth Factors Sales Estimates and Forecasts 2017-2028
2.2 Global Recombinant Growth Factors Revenue Estimates and Forecasts 2017-2028
2.3 Global Recombinant Growth Factors Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Recombinant Growth Factors Sales by Region
2.4.1 Global Recombinant Growth Factors Sales by Region (2017-2022)
2.4.2 Global Sales Recombinant Growth Factors by Region (2023-2028)
2.5 Global Recombinant Growth Factors Revenue by Region
2.5.1 Global Recombinant Growth Factors Revenue by Region (2017-2022)
2.5.2 Global Recombinant Growth Factors Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Recombinant Growth Factors Sales by Manufacturers
3.1.1 Global Top Recombinant Growth Factors Manufacturers by Sales (2017-2022)
3.1.2 Global Recombinant Growth Factors Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Growth Factors in 2021
3.2 Global Recombinant Growth Factors Revenue by Manufacturers
3.2.1 Global Recombinant Growth Factors Revenue by Manufacturers (2017-2022)
3.2.2 Global Recombinant Growth Factors Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant Growth Factors Revenue in 2021
3.3 Global Recombinant Growth Factors Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Recombinant Growth Factors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Recombinant Growth Factors Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Recombinant Growth Factors Sales by Type
4.1.1 Global Recombinant Growth Factors Historical Sales by Type (2017-2022)
4.1.2 Global Recombinant Growth Factors Forecasted Sales by Type (2023-2028)
4.1.3 Global Recombinant Growth Factors Sales Market Share by Type (2017-2028)
4.2 Global Recombinant Growth Factors Revenue by Type
4.2.1 Global Recombinant Growth Factors Historical Revenue by Type (2017-2022)
4.2.2 Global Recombinant Growth Factors Forecasted Revenue by Type (2023-2028)
4.2.3 Global Recombinant Growth Factors Revenue Market Share by Type (2017-2028)
4.3 Global Recombinant Growth Factors Price by Type
4.3.1 Global Recombinant Growth Factors Price by Type (2017-2022)
4.3.2 Global Recombinant Growth Factors Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Recombinant Growth Factors Sales by Application
5.1.1 Global Recombinant Growth Factors Historical Sales by Application (2017-2022)
5.1.2 Global Recombinant Growth Factors Forecasted Sales by Application (2023-2028)
5.1.3 Global Recombinant Growth Factors Sales Market Share by Application (2017-2028)
5.2 Global Recombinant Growth Factors Revenue by Application
5.2.1 Global Recombinant Growth Factors Historical Revenue by Application (2017-2022)
5.2.2 Global Recombinant Growth Factors Forecasted Revenue by Application (2023-2028)
5.2.3 Global Recombinant Growth Factors Revenue Market Share by Application (2017-2028)
5.3 Global Recombinant Growth Factors Price by Application
5.3.1 Global Recombinant Growth Factors Price by Application (2017-2022)
5.3.2 Global Recombinant Growth Factors Price Forecast by Application (2023-2028)
6 North America
6.1 North America Recombinant Growth Factors Market Size by Type
6.1.1 North America Recombinant Growth Factors Sales by Type (2017-2028)
6.1.2 North America Recombinant Growth Factors Revenue by Type (2017-2028)
6.2 North America Recombinant Growth Factors Market Size by Application
6.2.1 North America Recombinant Growth Factors Sales by Application (2017-2028)
6.2.2 North America Recombinant Growth Factors Revenue by Application (2017-2028)
6.3 North America Recombinant Growth Factors Market Size by Country
6.3.1 North America Recombinant Growth Factors Sales by Country (2017-2028)
6.3.2 North America Recombinant Growth Factors Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Recombinant Growth Factors Market Size by Type
7.1.1 Europe Recombinant Growth Factors Sales by Type (2017-2028)
7.1.2 Europe Recombinant Growth Factors Revenue by Type (2017-2028)
7.2 Europe Recombinant Growth Factors Market Size by Application
7.2.1 Europe Recombinant Growth Factors Sales by Application (2017-2028)
7.2.2 Europe Recombinant Growth Factors Revenue by Application (2017-2028)
7.3 Europe Recombinant Growth Factors Market Size by Country
7.3.1 Europe Recombinant Growth Factors Sales by Country (2017-2028)
7.3.2 Europe Recombinant Growth Factors Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Recombinant Growth Factors Market Size by Type
8.1.1 Asia Pacific Recombinant Growth Factors Sales by Type (2017-2028)
8.1.2 Asia Pacific Recombinant Growth Factors Revenue by Type (2017-2028)
8.2 Asia Pacific Recombinant Growth Factors Market Size by Application
8.2.1 Asia Pacific Recombinant Growth Factors Sales by Application (2017-2028)
8.2.2 Asia Pacific Recombinant Growth Factors Revenue by Application (2017-2028)
8.3 Asia Pacific Recombinant Growth Factors Market Size by Region
8.3.1 Asia Pacific Recombinant Growth Factors Sales by Region (2017-2028)
8.3.2 Asia Pacific Recombinant Growth Factors Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Recombinant Growth Factors Market Size by Type
9.1.1 Latin America Recombinant Growth Factors Sales by Type (2017-2028)
9.1.2 Latin America Recombinant Growth Factors Revenue by Type (2017-2028)
9.2 Latin America Recombinant Growth Factors Market Size by Application
9.2.1 Latin America Recombinant Growth Factors Sales by Application (2017-2028)
9.2.2 Latin America Recombinant Growth Factors Revenue by Application (2017-2028)
9.3 Latin America Recombinant Growth Factors Market Size by Country
9.3.1 Latin America Recombinant Growth Factors Sales by Country (2017-2028)
9.3.2 Latin America Recombinant Growth Factors Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Recombinant Growth Factors Market Size by Type
10.1.1 Middle East and Africa Recombinant Growth Factors Sales by Type (2017-2028)
10.1.2 Middle East and Africa Recombinant Growth Factors Revenue by Type (2017-2028)
10.2 Middle East and Africa Recombinant Growth Factors Market Size by Application
10.2.1 Middle East and Africa Recombinant Growth Factors Sales by Application (2017-2028)
10.2.2 Middle East and Africa Recombinant Growth Factors Revenue by Application (2017-2028)
10.3 Middle East and Africa Recombinant Growth Factors Market Size by Country
10.3.1 Middle East and Africa Recombinant Growth Factors Sales by Country (2017-2028)
10.3.2 Middle East and Africa Recombinant Growth Factors Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Corporation Information
11.1.2 Thermo Fisher Overview
11.1.3 Thermo Fisher Recombinant Growth Factors Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Thermo Fisher Recombinant Growth Factors Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Thermo Fisher Recent Developments
11.2 Irvine Scientific
11.2.1 Irvine Scientific Corporation Information
11.2.2 Irvine Scientific Overview
11.2.3 Irvine Scientific Recombinant Growth Factors Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Irvine Scientific Recombinant Growth Factors Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Irvine Scientific Recent Developments
11.3 Biologics International Corp
11.3.1 Biologics International Corp Corporation Information
11.3.2 Biologics International Corp Overview
11.3.3 Biologics International Corp Recombinant Growth Factors Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Biologics International Corp Recombinant Growth Factors Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biologics International Corp Recent Developments
11.4 R&D Systems
11.4.1 R&D Systems Corporation Information
11.4.2 R&D Systems Overview
11.4.3 R&D Systems Recombinant Growth Factors Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 R&D Systems Recombinant Growth Factors Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 R&D Systems Recent Developments
11.5 BioLegend
11.5.1 BioLegend Corporation Information
11.5.2 BioLegend Overview
11.5.3 BioLegend Recombinant Growth Factors Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 BioLegend Recombinant Growth Factors Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 BioLegend Recent Developments
11.6 Corning
11.6.1 Corning Corporation Information
11.6.2 Corning Overview
11.6.3 Corning Recombinant Growth Factors Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Corning Recombinant Growth Factors Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Corning Recent Developments
11.7 VWR
11.7.1 VWR Corporation Information
11.7.2 VWR Overview
11.7.3 VWR Recombinant Growth Factors Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 VWR Recombinant Growth Factors Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 VWR Recent Developments
11.8 CellGenix GmbH
11.8.1 CellGenix GmbH Corporation Information
11.8.2 CellGenix GmbH Overview
11.8.3 CellGenix GmbH Recombinant Growth Factors Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 CellGenix GmbH Recombinant Growth Factors Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 CellGenix GmbH Recent Developments
11.9 Shenandoah Biotechnology
11.9.1 Shenandoah Biotechnology Corporation Information
11.9.2 Shenandoah Biotechnology Overview
11.9.3 Shenandoah Biotechnology Recombinant Growth Factors Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Shenandoah Biotechnology Recombinant Growth Factors Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Shenandoah Biotechnology Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant Growth Factors Industry Chain Analysis
12.2 Recombinant Growth Factors Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Growth Factors Production Mode & Process
12.4 Recombinant Growth Factors Sales and Marketing
12.4.1 Recombinant Growth Factors Sales Channels
12.4.2 Recombinant Growth Factors Distributors
12.5 Recombinant Growth Factors Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Recombinant Growth Factors Industry Trends
13.2 Recombinant Growth Factors Market Drivers
13.3 Recombinant Growth Factors Market Challenges
13.4 Recombinant Growth Factors Market Restraints
14 Key Findings in The Global Recombinant Growth Factors Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Recombinant Growth Factors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Recombinant Human Epidermal Growth Factor
Table 3. Major Manufacturers of Other
Table 4. Global Recombinant Growth Factors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Recombinant Growth Factors Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Recombinant Growth Factors Sales by Region (2017-2022) & (Kg)
Table 7. Global Recombinant Growth Factors Sales Market Share by Region (2017-2022)
Table 8. Global Recombinant Growth Factors Sales by Region (2023-2028) & (Kg)
Table 9. Global Recombinant Growth Factors Sales Market Share by Region (2023-2028)
Table 10. Global Recombinant Growth Factors Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Recombinant Growth Factors Revenue Market Share by Region (2017-2022)
Table 12. Global Recombinant Growth Factors Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Recombinant Growth Factors Revenue Market Share by Region (2023-2028)
Table 14. Global Recombinant Growth Factors Sales by Manufacturers (2017-2022) & (Kg)
Table 15. Global Recombinant Growth Factors Sales Share by Manufacturers (2017-2022)
Table 16. Global Recombinant Growth Factors Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Recombinant Growth Factors Revenue Share by Manufacturers (2017-2022)
Table 18. Recombinant Growth Factors Price by Manufacturers (2017-2022) &(US$/Kg)
Table 19. Global Recombinant Growth Factors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Recombinant Growth Factors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Growth Factors as of 2021)
Table 21. Recombinant Growth Factors Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Recombinant Growth Factors Product Offered
Table 23. Date of Manufacturers Enter into Recombinant Growth Factors Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Recombinant Growth Factors Sales by Type (2017-2022) & (Kg)
Table 26. Global Recombinant Growth Factors Sales by Type (2023-2028) & (Kg)
Table 27. Global Recombinant Growth Factors Sales Share by Type (2017-2022)
Table 28. Global Recombinant Growth Factors Sales Share by Type (2023-2028)
Table 29. Global Recombinant Growth Factors Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Recombinant Growth Factors Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Recombinant Growth Factors Revenue Share by Type (2017-2022)
Table 32. Global Recombinant Growth Factors Revenue Share by Type (2023-2028)
Table 33. Recombinant Growth Factors Price by Type (2017-2022) & (US$/Kg)
Table 34. Global Recombinant Growth Factors Price Forecast by Type (2023-2028) & (US$/Kg)
Table 35. Global Recombinant Growth Factors Sales by Application (2017-2022) & (Kg)
Table 36. Global Recombinant Growth Factors Sales by Application (2023-2028) & (Kg)
Table 37. Global Recombinant Growth Factors Sales Share by Application (2017-2022)
Table 38. Global Recombinant Growth Factors Sales Share by Application (2023-2028)
Table 39. Global Recombinant Growth Factors Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Recombinant Growth Factors Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Recombinant Growth Factors Revenue Share by Application (2017-2022)
Table 42. Global Recombinant Growth Factors Revenue Share by Application (2023-2028)
Table 43. Recombinant Growth Factors Price by Application (2017-2022) & (US$/Kg)
Table 44. Global Recombinant Growth Factors Price Forecast by Application (2023-2028) & (US$/Kg)
Table 45. North America Recombinant Growth Factors Sales by Type (2017-2022) & (Kg)
Table 46. North America Recombinant Growth Factors Sales by Type (2023-2028) & (Kg)
Table 47. North America Recombinant Growth Factors Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Recombinant Growth Factors Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Recombinant Growth Factors Sales by Application (2017-2022) & (Kg)
Table 50. North America Recombinant Growth Factors Sales by Application (2023-2028) & (Kg)
Table 51. North America Recombinant Growth Factors Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Recombinant Growth Factors Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Recombinant Growth Factors Sales by Country (2017-2022) & (Kg)
Table 54. North America Recombinant Growth Factors Sales by Country (2023-2028) & (Kg)
Table 55. North America Recombinant Growth Factors Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Recombinant Growth Factors Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Recombinant Growth Factors Sales by Type (2017-2022) & (Kg)
Table 58. Europe Recombinant Growth Factors Sales by Type (2023-2028) & (Kg)
Table 59. Europe Recombinant Growth Factors Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Recombinant Growth Factors Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Recombinant Growth Factors Sales by Application (2017-2022) & (Kg)
Table 62. Europe Recombinant Growth Factors Sales by Application (2023-2028) & (Kg)
Table 63. Europe Recombinant Growth Factors Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Recombinant Growth Factors Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Recombinant Growth Factors Sales by Country (2017-2022) & (Kg)
Table 66. Europe Recombinant Growth Factors Sales by Country (2023-2028) & (Kg)
Table 67. Europe Recombinant Growth Factors Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Recombinant Growth Factors Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Recombinant Growth Factors Sales by Type (2017-2022) & (Kg)
Table 70. Asia Pacific Recombinant Growth Factors Sales by Type (2023-2028) & (Kg)
Table 71. Asia Pacific Recombinant Growth Factors Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Recombinant Growth Factors Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Recombinant Growth Factors Sales by Application (2017-2022) & (Kg)
Table 74. Asia Pacific Recombinant Growth Factors Sales by Application (2023-2028) & (Kg)
Table 75. Asia Pacific Recombinant Growth Factors Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Recombinant Growth Factors Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Recombinant Growth Factors Sales by Region (2017-2022) & (Kg)
Table 78. Asia Pacific Recombinant Growth Factors Sales by Region (2023-2028) & (Kg)
Table 79. Asia Pacific Recombinant Growth Factors Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Recombinant Growth Factors Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Recombinant Growth Factors Sales by Type (2017-2022) & (Kg)
Table 82. Latin America Recombinant Growth Factors Sales by Type (2023-2028) & (Kg)
Table 83. Latin America Recombinant Growth Factors Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Recombinant Growth Factors Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Recombinant Growth Factors Sales by Application (2017-2022) & (Kg)
Table 86. Latin America Recombinant Growth Factors Sales by Application (2023-2028) & (Kg)
Table 87. Latin America Recombinant Growth Factors Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Recombinant Growth Factors Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Recombinant Growth Factors Sales by Country (2017-2022) & (Kg)
Table 90. Latin America Recombinant Growth Factors Sales by Country (2023-2028) & (Kg)
Table 91. Latin America Recombinant Growth Factors Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Recombinant Growth Factors Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Recombinant Growth Factors Sales by Type (2017-2022) & (Kg)
Table 94. Middle East and Africa Recombinant Growth Factors Sales by Type (2023-2028) & (Kg)
Table 95. Middle East and Africa Recombinant Growth Factors Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Recombinant Growth Factors Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Recombinant Growth Factors Sales by Application (2017-2022) & (Kg)
Table 98. Middle East and Africa Recombinant Growth Factors Sales by Application (2023-2028) & (Kg)
Table 99. Middle East and Africa Recombinant Growth Factors Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Recombinant Growth Factors Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Recombinant Growth Factors Sales by Country (2017-2022) & (Kg)
Table 102. Middle East and Africa Recombinant Growth Factors Sales by Country (2023-2028) & (Kg)
Table 103. Middle East and Africa Recombinant Growth Factors Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Recombinant Growth Factors Revenue by Country (2023-2028) & (US$ Million)
Table 105. Thermo Fisher Corporation Information
Table 106. Thermo Fisher Description and Major Businesses
Table 107. Thermo Fisher Recombinant Growth Factors Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 108. Thermo Fisher Recombinant Growth Factors Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Thermo Fisher Recent Developments
Table 110. Irvine Scientific Corporation Information
Table 111. Irvine Scientific Description and Major Businesses
Table 112. Irvine Scientific Recombinant Growth Factors Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 113. Irvine Scientific Recombinant Growth Factors Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Irvine Scientific Recent Developments
Table 115. Biologics International Corp Corporation Information
Table 116. Biologics International Corp Description and Major Businesses
Table 117. Biologics International Corp Recombinant Growth Factors Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 118. Biologics International Corp Recombinant Growth Factors Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Biologics International Corp Recent Developments
Table 120. R&D Systems Corporation Information
Table 121. R&D Systems Description and Major Businesses
Table 122. R&D Systems Recombinant Growth Factors Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 123. R&D Systems Recombinant Growth Factors Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. R&D Systems Recent Developments
Table 125. BioLegend Corporation Information
Table 126. BioLegend Description and Major Businesses
Table 127. BioLegend Recombinant Growth Factors Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 128. BioLegend Recombinant Growth Factors Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. BioLegend Recent Developments
Table 130. Corning Corporation Information
Table 131. Corning Description and Major Businesses
Table 132. Corning Recombinant Growth Factors Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 133. Corning Recombinant Growth Factors Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Corning Recent Developments
Table 135. VWR Corporation Information
Table 136. VWR Description and Major Businesses
Table 137. VWR Recombinant Growth Factors Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 138. VWR Recombinant Growth Factors Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. VWR Recent Developments
Table 140. CellGenix GmbH Corporation Information
Table 141. CellGenix GmbH Description and Major Businesses
Table 142. CellGenix GmbH Recombinant Growth Factors Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 143. CellGenix GmbH Recombinant Growth Factors Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. CellGenix GmbH Recent Developments
Table 145. Shenandoah Biotechnology Corporation Information
Table 146. Shenandoah Biotechnology Description and Major Businesses
Table 147. Shenandoah Biotechnology Recombinant Growth Factors Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 148. Shenandoah Biotechnology Recombinant Growth Factors Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Shenandoah Biotechnology Recent Developments
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Recombinant Growth Factors Distributors List
Table 153. Recombinant Growth Factors Customers List
Table 154. Recombinant Growth Factors Market Trends
Table 155. Recombinant Growth Factors Market Drivers
Table 156. Recombinant Growth Factors Market Challenges
Table 157. Recombinant Growth Factors Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Growth Factors Product Picture
Figure 2. Global Recombinant Growth Factors Market Share by Type in 2021 & 2028
Figure 3. Recombinant Human Epidermal Growth Factor Product Picture
Figure 4. Other Product Picture
Figure 5. Global Recombinant Growth Factors Market Share by Application in 2021 & 2028
Figure 6. Scientific Research
Figure 7. Industrial Production
Figure 8. Recombinant Growth Factors Report Years Considered
Figure 9. Global Recombinant Growth Factors Sales 2017-2028 (Kg)
Figure 10. Global Recombinant Growth Factors Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Recombinant Growth Factors Revenue 2017-2028 (US$ Million)
Figure 12. Global Recombinant Growth Factors Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Recombinant Growth Factors Sales Market Share by Region (2017-2022)
Figure 14. Global Recombinant Growth Factors Sales Market Share by Region (2023-2028)
Figure 15. North America Recombinant Growth Factors Sales YoY (2017-2028) & (Kg)
Figure 16. North America Recombinant Growth Factors Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Recombinant Growth Factors Sales YoY (2017-2028) & (Kg)
Figure 18. Europe Recombinant Growth Factors Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Recombinant Growth Factors Sales YoY (2017-2028) & (Kg)
Figure 20. Asia-Pacific Recombinant Growth Factors Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Recombinant Growth Factors Sales YoY (2017-2028) & (Kg)
Figure 22. Latin America Recombinant Growth Factors Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Recombinant Growth Factors Sales YoY (2017-2028) & (Kg)
Figure 24. Middle East & Africa Recombinant Growth Factors Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Recombinant Growth Factors Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Recombinant Growth Factors in the World: Market Share by Recombinant Growth Factors Revenue in 2021
Figure 27. Global Recombinant Growth Factors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Recombinant Growth Factors Sales Market Share by Type (2017-2028)
Figure 29. Global Recombinant Growth Factors Revenue Market Share by Type (2017-2028)
Figure 30. Global Recombinant Growth Factors Sales Market Share by Application (2017-2028)
Figure 31. Global Recombinant Growth Factors Revenue Market Share by Application (2017-2028)
Figure 32. North America Recombinant Growth Factors Sales Market Share by Type (2017-2028)
Figure 33. North America Recombinant Growth Factors Revenue Market Share by Type (2017-2028)
Figure 34. North America Recombinant Growth Factors Sales Market Share by Application (2017-2028)
Figure 35. North America Recombinant Growth Factors Revenue Market Share by Application (2017-2028)
Figure 36. North America Recombinant Growth Factors Sales Share by Country (2017-2028)
Figure 37. North America Recombinant Growth Factors Revenue Share by Country (2017-2028)
Figure 38. United States Recombinant Growth Factors Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Recombinant Growth Factors Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Recombinant Growth Factors Sales Market Share by Type (2017-2028)
Figure 41. Europe Recombinant Growth Factors Revenue Market Share by Type (2017-2028)
Figure 42. Europe Recombinant Growth Factors Sales Market Share by Application (2017-2028)
Figure 43. Europe Recombinant Growth Factors Revenue Market Share by Application (2017-2028)
Figure 44. Europe Recombinant Growth Factors Sales Share by Country (2017-2028)
Figure 45. Europe Recombinant Growth Factors Revenue Share by Country (2017-2028)
Figure 46. Germany Recombinant Growth Factors Revenue (2017-2028) & (US$ Million)
Figure 47. France Recombinant Growth Factors Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Recombinant Growth Factors Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Recombinant Growth Factors Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Recombinant Growth Factors Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Recombinant Growth Factors Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Recombinant Growth Factors Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Recombinant Growth Factors Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Recombinant Growth Factors Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Recombinant Growth Factors Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Recombinant Growth Factors Revenue Share by Region (2017-2028)
Figure 57. China Recombinant Growth Factors Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Recombinant Growth Factors Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Recombinant Growth Factors Revenue (2017-2028) & (US$ Million)
Figure 60. India Recombinant Growth Factors Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Recombinant Growth Factors Revenue (2017-2028) & (US$ Million)
Figure 62. China Taiwan Recombinant Growth Factors Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Recombinant Growth Factors Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Recombinant Growth Factors Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Recombinant Growth Factors Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America Recombinant Growth Factors Sales Market Share by Type (2017-2028)
Figure 67. Latin America Recombinant Growth Factors Revenue Market Share by Type (2017-2028)
Figure 68. Latin America Recombinant Growth Factors Sales Market Share by Application (2017-2028)
Figure 69. Latin America Recombinant Growth Factors Revenue Market Share by Application (2017-2028)
Figure 70. Latin America Recombinant Growth Factors Sales Share by Country (2017-2028)
Figure 71. Latin America Recombinant Growth Factors Revenue Share by Country (2017-2028)
Figure 72. Mexico Recombinant Growth Factors Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil Recombinant Growth Factors Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina Recombinant Growth Factors Revenue (2017-2028) & (US$ Million)
Figure 75. Middle East and Africa Recombinant Growth Factors Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Recombinant Growth Factors Revenue Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Recombinant Growth Factors Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Recombinant Growth Factors Revenue Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Recombinant Growth Factors Sales Share by Country (2017-2028)
Figure 80. Middle East and Africa Recombinant Growth Factors Revenue Share by Country (2017-2028)
Figure 81. Turkey Recombinant Growth Factors Revenue (2017-2028) & (US$ Million)
Figure 82. Saudi Arabia Recombinant Growth Factors Revenue (2017-2028) & (US$ Million)
Figure 83. UAE Recombinant Growth Factors Revenue (2017-2028) & (US$ Million)
Figure 84. Recombinant Growth Factors Value Chain
Figure 85. Recombinant Growth Factors Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed